Cargando…

A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection

Stimulation of innate immunity can protect against infectious insult and could be used in combination with other therapies. Since antibiotic resistance is an increasing concern, strategies to reduce the dose or eliminate the need for these drugs are warranted. Lipo-CRX is a formulation in which the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedges, Jodi F., Snyder, Deann T., Robison, Amanda, Thompson, Macy A., Aspelin, Klara, Plewa, Jack, Baldridge, Jory, Jutila, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331211/ https://www.ncbi.nlm.nih.gov/pubmed/37083049 http://dx.doi.org/10.1177/17534259231168725

Ejemplares similares

Expression of human TLR4/myeloid differentiation factor 2 directs an early innate immune response associated with modest increases in bacterial burden during Coxiella burnetii infection
por: Robison, Amanda, et al.
Publicado: (2019)

Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination
por: Hedges, Jodi F., et al.
Publicado: (2021)

Getting “Inside” Type I IFNs: Type I IFNs in Intracellular Bacterial Infections
por: Snyder, Deann T., et al.
Publicado: (2017)

Complete Genome Sequence of Brucella abortus Phage EF4, Determined Using Long-Read Sequencing
por: Cicha, Calvin, et al.
Publicado: (2020)

An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model
por: Hedges, Jodi F., et al.
Publicado: (2022)

Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure
por: Loveday, Emma K., et al.
Publicado: (2021)

Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
por: Jensen, Simon S, et al.
Publicado: (2013)

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
por: Gadd, Adam J.R., et al.
Publicado: (2018)

Polysaccharides Isolated from Açaí Fruit Induce Innate Immune Responses
por: Holderness, Jeff, et al.
Publicado: (2011)

Harnessing γδ T Cells as Natural Immune Modulators
por: Hedges, Jodi F., et al.
Publicado: (2020)

651: SARS-COV-2 IS DETECTED IN THE GASTROINTESTINAL TRACT OF ASYMPTOMATIC OUTPATIENTS USING ROUTINE ENDOSCOPY BUT POSES MINIMAL TRANSMISSION RISK
por: Gentry, Andrew B., et al.
Publicado: (2022)

SARS-CoV-2 genomic surveillance identifies naturally occurring truncations of ORF7a that limit immune suppression.
por: Nemudryi, Artem, et al.
Publicado: (2021)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
por: Liang, Hong, et al.
Publicado: (2022)

SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
por: Nemudryi, Artem, et al.
Publicado: (2021)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Antiviral response mechanisms in a Jamaican Fruit Bat intestinal organoid model of SARS-CoV-2 infection
por: Hashimi, Marziah, et al.
Publicado: (2022)

Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
por: Tom, Janine K., et al.
Publicado: (2015)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
por: Kim, Sehui, et al.
Publicado: (2023)

Stimulation of Innate Immune Cells by Light-Activated TLR7/8 Agonists
por: Ryu, Keun Ah, et al.
Publicado: (2014)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
por: Wheat, William, et al.
Publicado: (2019)

TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
por: Mifsud, Edin J., et al.
Publicado: (2014)

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015)

Innate Immune Receptors in Human Airway Smooth Muscle Cells: Activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 Agonists
por: Månsson Kvarnhammar, Anne, et al.
Publicado: (2013)

Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infection
por: Hashimi, Marziah, et al.
Publicado: (2023)

Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist
por: Ryu, Keun Ah, et al.
Publicado: (2017)

Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic
por: Santiago-Frangos, Andrew, et al.
Publicado: (2021)

Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
por: Lu, Ti, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Is Detected in the Gastrointestinal Tract of Asymptomatic Endoscopy Patients but Is Unlikely to Pose a Significant Risk to Healthcare Personnel
por: Cherne, Michelle D., et al.
Publicado: (2022)

Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations
por: Ko, Joungbo, et al.
Publicado: (2023)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
por: Dold, L., et al.
Publicado: (2020)

Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
por: Milicic, Anita, et al.
Publicado: (2012)

Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer
por: Chang, Rui, et al.
Publicado: (2023)

Formulation and Evaluation of Celastrol-Loaded Liposomes
por: Song, Jie, et al.
Publicado: (2011)

Development and characterization of liposomal formulation of bortezomib
por: Deshantri, Anil K., et al.
Publicado: (2019)

Eicosanoids in the Innate Immune Response: TLR and Non-TLR Routes
por: Alvarez, Yolanda, et al.
Publicado: (2010)

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
por: Tamir, Hadas, et al.
Publicado: (2022)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
por: Van Hoeven, Neal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_68g0ih9meiefepgbeo3l4c94cj